Pharma in Healthcare
CPHI Milan pharma award winners receive recognition
Every year on the first day of the worldwide show – CPHI Milan – runs the CPHI Celebration, where...
Abbott receives FDA approval for new CardioMEMS HF system capabilities that help patients engage in the care of their heart condition
The US Food and Drug Administration (FDA) has approved for Abbott’s updates to the CardioMEMS HF System that enable...
American Regent issues voluntary nationwide recall of three lots of epinephrine injection, due to the presence of particulate matter and lack of assurance of...
American Regent is conducting a nationwide voluntary recall of three lots of epinephrine injection, USP 30 mg/30 mL (1 mg/mL)...
Roche expands cyclospora testing portfolio to support US public health response
As a cyclospora outbreak continues to spread throughout the United States, Roche, in collaboration with subsidiary TIB MOLBIOL, has made...
Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
The European Commission (EC) has approved an extension of the indication for Sanofi’s MenQuadfi (meningococcal Group A, C, W...
Nipro Corporation receives FDA 510(k) clearance for Elisio-HX, introducing HDs to the United States
Nipro Corporation has been granted 510(k) clearance for the Elisio-HX dialyser by the United States Food and Drug Administration...
European Commission authorises Pfizer and BioNTech XFG-adapted COVID-19 vaccine in the European Union
Pfizer and BioNTech SE have been granted marketing authorisation by the European Commission (EC) for the companies’ 2026-2027 COVID-19...
IBSA foundation fellowships shatter records with unprecedented global reach and opens 2026 call
IBSA Foundation (Institut Biochimique SA) for scientific research, recently announced a record-shattering year for its prestigious fellowship programme, drawing an unprecedented...
Acute myocardial infarction market is expected to hit growth stride at a CAGR of 13% during the forecast period (2026-2036) with new therapeutic innovations
Recently published acute myocardial infarction market insights report includes a comprehensive understanding of current treatment practices, acute myocardial infarction...
Charcot-Marie-Tooth disease market growth to accelerate significantly during the forecast period (2026-2036) driven by the launch of emerging disease-modifying therapies
Recently published Charcot–Marie–Tooth Disease Market Insights report includes a comprehensive understanding of current treatment practices, Charcot–Marie–Tooth disease emerging drugs,...
Tyra Biosciences and the Bladder Cancer Advocacy Network have established 21 May as upper tract urothelial cancer awareness day
Tyra Biosciences has announced the establishment of Upper Tract Urothelial Cancer (UTUC) Awareness Day, in collaboration with the Bladder...
Valion Bio briefs senior Department of War and BARDA officials in joint engagement on Entolimod for acute radiation syndrome
Valion Bio, a late-stage innate immunotherapeutics company, has announced that it presented Entolimod for acute radiation syndrome (ARS) to senior...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Popular